Exome Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.06M	Sell	444,949 -244,188	-35%	-$1.68M	2.28%	14
2025 Q1	$1.98M	Buy	689,137 +405,538	+143%	+$1.17M	1.76%	27
2024 Q4	$1.33M	Buy	+283,599	New	+$1.33M	1%	37
2024 Q3	–	Sell	-302,700	Closed	-$1.88M	–	70
2024 Q2	$1.88M	Buy	+302,700	New	+$1.88M	1.67%	29